Recent updates of centromere proteins in hepatocellular carcinoma: a review
Abstract Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide, with approximately 800,000 deaths worldwide each year. Owing to the atypical early symptoms and characteristics of HCC, over 80% of HCC patients cannot receive curative treatment. The treatment of...
Saved in:
Main Authors: | Zhongyuan Yang, Wenjiao Chen, Yunhui Liu, Yuxin Niu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | Infectious Agents and Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13027-024-00630-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
by: V. V. Petkau, et al.
Published: (2022-12-01) -
Prognostic impact of presenting symptoms of patients with hepatocellular carcinoma
by: Samuel Jun Ming Lim, et al.
Published: (2024-08-01) -
Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study
by: Biling Gan, et al.
Published: (2025-02-01) -
Microfilaria coexisting with multifocal hepatocellular carcinoma: A case report
by: Ruchi Sinha, et al.
Published: (2025-01-01) -
Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)